Venezuela - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Hormones Price in Venezuela - 2022
Contents:
- Medicaments Containing Hormones Price in Venezuela (CIF) - 2022
- Medicaments Containing Hormones Imports in Venezuela
Medicaments Containing Hormones Price in Venezuela (CIF) - 2022
In 2022, the average medicaments containing hormones import price amounted to $42,821 per ton, increasing by 2.7% against the previous year. Overall, the import price posted a notable expansion. The pace of growth was the most pronounced in 2019 when the average import price increased by 27% against the previous year. As a result, import price reached the peak level of $76,627 per ton. From 2020 to 2022, the average import prices remained at a lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the United States ($95,807 per ton), while the price for Colombia ($3,754 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (+15.8%), while the prices for the other major suppliers experienced more modest paces of growth.
Medicaments Containing Hormones Imports in Venezuela
Medicaments containing hormones imports into Venezuela contracted notably to 14 tons in 2022, declining by -35.4% compared with 2021 figures. Over the period under review, imports continue to indicate a deep slump. The most prominent rate of growth was recorded in 2021 with an increase of 238% against the previous year. As a result, imports attained the peak of 21 tons, and then declined markedly in the following year.
In value terms, medicaments containing hormones imports declined dramatically to $580K in 2022. In general, imports recorded a sharp contraction. The most prominent rate of growth was recorded in 2021 with an increase of 206% against the previous year.
| Import of Medicaments Containing Hormones in Venezuela (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Switzerland | 228 | 139 | 332 | 255 | 3.8% |
| United States | 78.8 | 4.5 | 91.5 | 111 | 12.1% |
| India | 33.3 | 29.3 | 83.3 | 107 | 47.6% |
| Netherlands | 73.4 | 49.0 | 107 | 75.6 | 1.0% |
| Brazil | N/A | 2.4 | 11.0 | 11.8 | 121.7% |
| Colombia | 0.3 | 2.7 | 0.6 | 1.3 | 63.0% |
| El Salvador | 708 | N/A | N/A | N/A | 0% |
| Others | 90.4 | 59.0 | 248 | 18.0 | -41.6% |
| Total | 1,212 | 285 | 874 | 580 | -21.8% |
Top Suppliers of Medicaments Containing Hormones to Venezuela in 2022:
- Switzerland (8.6 tons)
- India (1.9 tons)
- Netherlands (1.2 tons)
- United States (1.2 tons)
- Colombia (0.4 tons)
- Brazil (0.3 tons)
This report provides an in-depth analysis of the medicaments containing hormones market in Venezuela. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)
Country coverage:
- Venezuela
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Venezuela
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
323
This report provides an in-depth analysis of the medicaments containing hormones market in Venezuela.
257
This report provides an in-depth analysis of the medicaments containing insulin market in Venezuela.
240
This report provides an in-depth analysis of the medicaments containing penicillin market in Venezuela.
139
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Venezuela.
248
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Venezuela.
264
This report provides an in-depth analysis of the market for medicaments of other antibiotics in Venezuela.
479
This report provides an in-depth analysis of the global medicaments containing hormones market.
476
This report provides an in-depth analysis of the global medicaments containing insulin market.
567
This report provides an in-depth analysis of the global medicaments containing penicillin market.
305
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
73
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
73
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
